Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Return to Sender who wrote (1288)	7/2/2000 6:03:04 AM
From: tuck	Read Replies (1) \| Respond to of 52153

RTS, Nigel recently started one on that subject. Some of the ususal suspects post there once in a while. Subject 34665 It seems the only point of commonality with regard to small molecules might be their markets. My understanding is that small molecules are required to get by the blood-brain barrier, so I would expect some of those common markets to be folks with CNS problems, for example. Per Peter's ruminations, and the ensuing response, I won't bother with a SM thread now (besides this is family portal!). Perhaps the best way to categorize biotech discussion threads -- or those of any industries -- is by their markets, rather than how their products work. Oncology companies, metabolic disease companies, etc., as thread titles, and start the discussion from there. Or maybe right down to the indication: breast cancer, diabetes, Alzheimers, etc. That might be apropos for the more widespread diseases, anyhow. What do y'all think of that? Cheers, Tuck